| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |